
Testosterone pellets are implanted under the skin and release hormone over months. Injections release hormone from a depot over a product-specific interval. Pellets can reduce repeated dosing tasks but require a procedure and offer less flexibility if treatment needs to change. Both can raise hematocrit and suppress sperm production. The choice depends on whether the convenience of duration outweighs the loss of adjustability.12
Key points
- The Testopel label describes effects commonly lasting three to four months, sometimes up to six.1
- Pellet extrusion and implant-site infection are recognized complications.1
- The injection category includes both shorter-acting preparations and long-acting clinic products.24
How do pellets and injections deliver testosterone?
Testopel pellets contain crystalline testosterone intended for subcutaneous implantation. The material releases hormone gradually after insertion. An oil-based injection instead creates a depot from which an esterified testosterone preparation is released. The active hormonal effects overlap, while the delivery and practical constraints differ. 1 2
The July 2025 Testopel label says adequate effects ordinarily continue for three to four months and sometimes as long as six. That is a description of observed duration, not a promise that every person can book identical intervals. The amount implanted, individual response and the clinical monitoring plan affect when another decision is needed. 1
The word pellet also does not identify every preparation sold under that description. FDA-approved Testopel and a compounded implant should not be assumed to share identical manufacturing, release characteristics or evidence. A useful comparison starts with the exact product rather than a marketing term such as bioidentical.
What happens if the treatment needs to be changed?
Pellets are less flexible after administration. The Testopel label specifically notes that implantation is harder to adjust than oral treatment or injections and that complications requiring discontinuation of testosterone effects may require pellet removal. Removal itself is a clinical procedure, not the equivalent of skipping tomorrow's application. 1
Injections also leave medicine in the body after administration. However, later injections can be withheld or changed under a clinician's plan without retrieving an implant. A long-acting injection remains a longer commitment than a shorter-acting one, so the advantage is a matter of degree rather than instant reversibility. 2 4
This makes uncertainty before treatment especially relevant. If the effective regimen is not established, symptoms may have another cause, or hematocrit has been difficult to control, the ability to reassess promptly has value. A longer delivery interval is most useful when the treatment itself already has a clear rationale.

Which practical differences should be compared?
Compare repeated tasks, procedure burden and the ability to respond to new information. Fewer medication days do not necessarily mean fewer healthcare obligations.
| Decision factor | Pellets | Injections |
|---|---|---|
| Administration | Implantation procedure, then gradual release. 1 | Repeated injections at product-specific intervals. 2 |
| Local problems | Wound issues, infection or pellet extrusion. 1 | Needle discomfort and site reactions; risks vary by product. 2 4 |
| Changing exposure | Limited once implanted; removal may be needed for some complications. 1 | Change future administrations; existing depot still releases medicine. 2 |
| Monitoring | Laboratory and symptom follow-up continues between procedures. 2 | Laboratory timing must match the injection interval. 2 |
| Household contact | No testosterone-coated application site. 1 | No testosterone-coated application site. 2 |
| Costs to request | Drug, implantation, follow-up and complication or removal policies. | Drug, supplies or administration visits, and follow-up. |
The final row is a budgeting framework rather than a measured price survey. Ask for the actual quote and what it includes. A procedure price and a monthly medication price are different units, so neither can be judged without an agreed period of comparison.
What are the distinctive risks of pellet insertion?
The distinctive risk is the implantation site. Testopel postmarketing reports include infection, abscess, extrusion and combinations of these problems. Reported symptoms include pain, redness, drainage, bleeding, bruising and changes in the tissue around the insertion. Most reported infection or extrusion cases occurred within the first month, although they can occur later. 1
Those reports identify possible complications; they do not provide a reliable percentage for every clinic or insertion technique. A claim that pellets never extrude is unsupported, and a complication rate from one practice should not automatically be applied to another.
Before a procedure, clarify wound-care instructions, activity restrictions, how to reach the clinical team and what to do if a pellet appears to come out. Do not attempt to reinsert it. Increasing pain, spreading redness, fever or drainage needs assessment. A local problem can affect both recovery from the procedure and confidence in the delivered treatment.
Do pellets avoid the high-hematocrit risk of injections?
No. Pellets still expose the bone marrow to testosterone and can raise hematocrit. In one retrospective comparison, erythrocytosis above a 50% hematocrit threshold occurred in 35.1% of pellet users, compared with 66.7% of injection users and 12.8% of gel users. Different baseline characteristics and achieved hormone levels limit a causal interpretation. 3
The useful conclusion is that delivery choices can influence the blood-count response and that pellets are not exempt from monitoring. The percentages cannot predict an individual's outcome, and the study's threshold is not the same as every guideline intervention threshold. 2 3
The hematocrit monitoring article explains why clinicians consider starting values, hypoxia, sleep apnea and other contributors. If hematocrit rises soon after pellet insertion, the treatment's limited adjustability becomes part of the management discussion. The procedure does not justify waiting until the next planned insertion to review a concerning result.

Do pellets work better or feel more natural?
The reviewed evidence does not establish that pellets produce universally better symptoms than an appropriately managed injectable regimen. All three formulations in the retrospective comparison raised testosterone, but the study was primarily a comparison of laboratory parameters and adverse effects rather than a randomized test of patient preference or symptom superiority. 3
Descriptions such as steady or natural can conceal two different claims. A gradual release profile describes drug delivery. Better libido, function or wellbeing describes a patient outcome. The first does not prove the second, and a long release period does not exactly reproduce the body's endogenous rhythms. 1 2
Define the outcome before choosing a procedure. The results timeline explains why a blood level, a symptom change and a longer-term clinical endpoint should be assessed separately. If a prior route did not help, review whether the problem was exposure, tolerability or the underlying diagnosis before expecting pellets to solve it.
Who might value the longer interval, and what should be settled first?
A man who has a clear indication for replacement, a demonstrated response and difficulty sustaining repeated administration may value a longer interval. That preference should be weighed with a clinician against procedure tolerance, access to follow-up, fertility plans and the ability to change treatment if risks emerge. 1 2
A shorter medication to-do list does not remove suppression of reproductive signaling. Pellets and injections both supply external testosterone, so future conception needs the same early discussion. Read how testosterone affects sperm before treating route choice as fertility planning. 2
Convenience and control move in different directions. Pellets concentrate the work into a procedure but make later changes harder. Compare that tradeoff with the actual injectable alternative and with the full cost of care, including repeat procedures and follow-up, before deciding whether the longer interval is an advantage.
Common questions
Are pellets permanent?
They are designed to release testosterone gradually rather than remain as a permanent device. Their effects last for a variable period, and an insertion cannot be assumed to deliver exactly the same duration for every person.1
Can I skip monitoring until the next insertion?
No. Symptoms and safety findings can change between procedures. The need for hematocrit, testosterone and other monitoring follows the treatment plan and risks, not just the date of the next implant.2
References
- 1.Endo USA. Testopel prescribing information. DailyMed, effective July 17, 2025.
- 2.Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018.
- 3.Pastuszak AW, et al. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sexual Medicine. 2015.
- 4.Endo USA. Aveed prescribing information. DailyMed, effective July 15, 2025.
This article is for general education, not medical advice, diagnosis or a treatment recommendation. A licensed clinician can interpret the evidence in the context of your symptoms, tests, medicines and fertility plans.